Lam Shiu Kum, Lau George
Humanity & Health GI & Liver Centre, Humanity & Health Medical Group Hong Kong SAR China.
Humanity & Health Clinical Trial Centre Humanity & Health Medical Group, Hong Kong SAR China.
JGH Open. 2020 Mar 13;4(4):569-573. doi: 10.1002/jgh3.12318. eCollection 2020 Aug.
Gastric intestinal metaplasia (GIM) is precancerous with a worldwide prevalence of 25%. Eradicating prevented about half of gastric cancers; failure to prevent the rest was attributed to GIM. GIM is irreversible and often extensive. There is no treatment. Existing endoscopic mucosal resection (EMR) is designed to treat early gastric cancer of usually <2 cm. We designed a -endoscope technique of EMR for extensive lesions such as GIM.
Forty patients with histologically confirmed moderate to severe GIM (operative link on GIM [OLGIM] classification) received the treatment in a daycare center. Chromoendoscopy with methylene blue was first performed to indicate the GIM. Submucosal saline injections were used to lift the stained mucosa to form multiple safety cushions, which were transformed into artificial polyps by suction and ligation, using a cap familiar to gastroenterologists for ligation of esophageal varices. EMRs were then achieved by snare polypectomy. By rotating two gastroscopes, one was designated to perform lift and snare and the other to perform suction and ligation; cycles of lift-ligate-snare were performed until all stained mucosa was removed. Assessment chromoendoscopy with ≥seven biopsies was performed at 6 months.
A total of 227 EMRs were performed, with a median of 3.5 per patient. Bleeding was uncommon and minimal. Gastric perforation ascribable to loss of a safety cushion occurred in one patient. Chromoendoscopy at 6 months in 36 willing patients showed no recurrence of GIM.
The two-endoscope technique of EMR for GIM was essentially safe and effective, with no recurrence at 6 months. It could be performed by endoscopists with standard skills.
胃黏膜肠化生(GIM)是癌前病变,在全球范围内的患病率为25%。根除幽门螺杆菌可预防约一半的胃癌;未能预防其余部分则归因于GIM。GIM是不可逆的,且通常范围广泛。目前尚无治疗方法。现有的内镜黏膜切除术(EMR)旨在治疗通常小于2厘米的早期胃癌。我们设计了一种用于治疗如GIM等广泛病变的双内镜EMR技术。
40例经组织学证实为中重度GIM(基于GIM的手术链接[OLGIM]分类)的患者在日间护理中心接受治疗。首先进行亚甲蓝染色内镜检查以明确GIM。通过黏膜下注射生理盐水抬起染色的黏膜以形成多个安全垫,使用胃肠病学家熟悉的用于结扎食管静脉曲张的套扎帽,通过吸引和结扎将其转化为人工息肉。然后通过圈套息肉切除术进行EMR。通过旋转两根胃镜,一根用于抬起和圈套,另一根用于吸引和结扎;重复抬起 - 结扎 - 圈套的操作循环,直到所有染色的黏膜被切除。在6个月时进行评估性染色内镜检查,并取≥7块活检组织。
共进行了227次EMR,每位患者平均3.5次。出血罕见且轻微。1例患者因安全垫丢失导致胃穿孔。36例愿意接受检查的患者在6个月时的染色内镜检查显示GIM无复发。
用于GIM的双内镜EMR技术基本安全有效,6个月时无复发。具备标准技能的内镜医师即可实施该技术。